Fundraising Fox
Nanophage
11 employees on LinkedIn · 2 known investors
Find your way into Nanophage
Each arrow is one introduction. Sign up to fill in the first one.
140 people can intro you to Paul
Ask John Robson to introduce you to Paul Smith
You →John · together at Nanophage →Paul
Sign up to find every way you can get introduced to Nanophage
- Your email: who you already know at Nanophage, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Nanophage team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Nanophage Technologies develops biological nanorod scaffolds for diagnostic assay applications, enabling enhanced detection and sensitivity in clinical and research settings. The company serves diagnostics manufacturers, pharmaceutical discovery organizations, and clinical laboratories.
Founders & leadership
PS
Paul SmithChief Executive OfficerPaul Smith began his career as a research chemist before transitioning to consulting and marketing leadership roles. He brings over ten years of managing director experience scaling science-based businesses across multiple regions including New Zealand, French territories, and Australia, with track records of driving revenue growth and operational efficiency.
DS
Dr Stuart BlinckoChief Technology Officer
Investors · 2
Frequently asked questions
- What does Nanophage do?
- Nanophage Technologies develops biological nanorod scaffolds for diagnostic assay applications, enabling enhanced detection and sensitivity in clinical and research settings. The company serves diagnostics manufacturers, pharmaceutical discovery organizations, and clinical laboratories.
- Who are Nanophage's investors?
- Nanophage's investors include Angel HQ, Bridgewest Ventures.
- Where is Nanophage headquartered?
- Nanophage is headquartered in Unknown, NZ.